KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,800,946 | -53.2% | 117,103 | -39.9% | 0.01% | -57.1% |
Q2 2023 | $42,280,979 | +1467480.0% | 194,978 | +1230.0% | 0.02% | +950.0% |
Q4 2022 | $2,881 | -100.0% | 14,660 | -73.7% | 0.00% | -71.4% |
Q3 2022 | $12,548,000 | +88.3% | 55,787 | +5.9% | 0.01% | +40.0% |
Q2 2022 | $6,665,000 | +1214.6% | 52,679 | +1217.3% | 0.01% | – |
Q1 2022 | $507,000 | -64.0% | 3,999 | -62.9% | 0.00% | -100.0% |
Q4 2021 | $1,410,000 | -48.4% | 10,766 | -51.8% | 0.00% | -50.0% |
Q3 2021 | $2,734,000 | +197.8% | 22,348 | +192.6% | 0.00% | – |
Q1 2021 | $918,000 | -84.1% | 7,637 | -86.6% | 0.00% | -100.0% |
Q4 2020 | $5,771,000 | +62.7% | 56,807 | +23.8% | 0.00% | 0.0% |
Q3 2020 | $3,547,000 | +174.3% | 45,872 | +295.6% | 0.00% | +100.0% |
Q2 2020 | $1,293,000 | +112.0% | 11,597 | -69.0% | 0.00% | +100.0% |
Q3 2019 | $610,000 | -57.1% | 37,398 | -47.3% | 0.00% | -50.0% |
Q2 2019 | $1,421,000 | – | 70,968 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |